A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team ...

Gemogenovatucel-T is a DNA-engineered, triple-function immunotherapy that utilizes a patient's autologous tumor cells as a source for the complete matrix of tumor-related clonal signals. Its mechanism ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...

Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...

In August 2015, former President Jimmy Carter thought he had mere weeks to live. His skin cancer ‒ metastatic melanoma ‒ had seeded malignant tumors in his liver and brain. Conventional radiation ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Lawrence Fong, MD’s research has focused on immunotherapy for more than 30 years. For many of those years, the new scientific director of the Immunotherapy Integrated Research Center at Fred Hutch ...

Bowel cancer is the second-leading cause of cancer deaths worldwide, killing nearly 1 million people per year, and cases of colorectal cancer have been on the rise. But there are glimmers of hope ...

Healthcare professionals may use immunotherapy as part of the treatment for someone with Hodgkin’s lymphoma. They may also use it as part of palliative therapy to improve a person’s quality of life ...